Cengild Medical Berhad (KLSE:CENGILD)
0.2250
-0.0050 (-2.17%)
At close: Feb 16, 2026
Cengild Medical Berhad Balance Sheet
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Equivalents | 4.85 | 11.8 | 1.92 | 0.76 | 5.83 | 0.65 |
Short-Term Investments | 60.6 | 73.45 | 88.5 | 98.27 | 81.24 | 6.35 |
Cash & Short-Term Investments | 65.45 | 85.24 | 90.42 | 99.03 | 87.07 | 6.99 |
Cash Growth | -30.89% | -5.72% | -8.70% | 13.74% | 1145.04% | 10.89% |
Accounts Receivable | 7.36 | 8.79 | 6.55 | 5.08 | 4.78 | 4.5 |
Other Receivables | 2.66 | 1.78 | 0.38 | 0.41 | 0.33 | 0.1 |
Receivables | 10.02 | 10.57 | 6.93 | 5.49 | 5.11 | 4.59 |
Inventory | 2.13 | 2.05 | 1.72 | 1.38 | 1.15 | 0.94 |
Prepaid Expenses | - | 0.57 | 0.33 | 0.26 | 0.4 | 0.13 |
Total Current Assets | 77.59 | 98.44 | 99.39 | 106.17 | 93.74 | 12.65 |
Property, Plant & Equipment | 133.66 | 75.62 | 30.2 | 23.89 | 24.35 | 33.32 |
Long-Term Investments | 3.95 | 3.4 | 0.92 | 0 | 0 | 0 |
Long-Term Deferred Tax Assets | 2.42 | 2.42 | 1.93 | 1.67 | 1.45 | - |
Other Long-Term Assets | 0.44 | 0.61 | - | - | - | - |
Total Assets | 218.07 | 180.49 | 132.44 | 131.73 | 119.54 | 45.98 |
Accounts Payable | 8.39 | 9.42 | 5.15 | 2.59 | 3.52 | 5.3 |
Accrued Expenses | 0.04 | 3.09 | 2.98 | 4.2 | 3.47 | 1.7 |
Short-Term Debt | - | - | - | - | - | 2.02 |
Current Portion of Leases | 2.39 | 2.32 | 2.48 | 1.33 | 1.27 | 0.91 |
Current Income Taxes Payable | 1.59 | 1.65 | 0.98 | 0.29 | 0.33 | 0.47 |
Other Current Liabilities | 7.47 | 3.58 | 3.17 | 2.98 | 3.07 | 0.54 |
Total Current Liabilities | 19.88 | 20.05 | 14.77 | 11.4 | 11.66 | 10.95 |
Long-Term Debt | 79.22 | 42.82 | - | - | - | - |
Long-Term Leases | 1.23 | 2.41 | 5.67 | 13.6 | 14.93 | 21.25 |
Other Long-Term Liabilities | 0.76 | 0.75 | 0.72 | 0.62 | - | - |
Total Liabilities | 101.09 | 66.03 | 21.15 | 25.62 | 26.59 | 32.2 |
Common Stock | 87.49 | 87.49 | 87.49 | 87.47 | 81.93 | 12.24 |
Retained Earnings | 27.02 | 24.52 | 21.54 | 16.63 | 9.4 | 0.01 |
Comprehensive Income & Other | 2.48 | 2.45 | 2.27 | 2.01 | 1.62 | 1.53 |
Shareholders' Equity | 116.98 | 114.46 | 111.3 | 106.11 | 92.95 | 13.78 |
Total Liabilities & Equity | 218.07 | 180.49 | 132.44 | 131.73 | 119.54 | 45.98 |
Total Debt | 82.84 | 47.55 | 8.14 | 14.93 | 16.21 | 24.18 |
Net Cash (Debt) | -17.39 | 37.69 | 82.27 | 84.1 | 70.87 | -17.19 |
Net Cash Growth | - | -54.18% | -2.17% | 18.67% | - | - |
Net Cash Per Share | -0.02 | 0.05 | 0.10 | 0.10 | 0.11 | -0.03 |
Filing Date Shares Outstanding | 832.91 | 832.91 | 832.91 | 832.91 | 818.8 | 600 |
Total Common Shares Outstanding | 832.91 | 832.91 | 832.91 | 832.87 | 818.8 | 600 |
Working Capital | 57.71 | 78.38 | 84.62 | 94.77 | 82.08 | 1.7 |
Book Value Per Share | 0.14 | 0.14 | 0.13 | 0.13 | 0.11 | 0.02 |
Tangible Book Value | 116.98 | 114.46 | 111.3 | 106.11 | 92.95 | 13.78 |
Tangible Book Value Per Share | 0.14 | 0.14 | 0.13 | 0.13 | 0.11 | 0.02 |
Machinery | - | 17.78 | 15.99 | 13.34 | 12.42 | 12.19 |
Construction In Progress | - | 63.38 | 12.71 | 0.55 | 0.18 | - |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.